208 related articles for article (PubMed ID: 20066732)
21. Clostridium difficile.
Kyne L; Farrell RJ; Kelly CP
Gastroenterol Clin North Am; 2001 Sep; 30(3):753-77, ix-x. PubMed ID: 11586556
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiology, diagnosis and treatment of Clostridium difficile infection.
Castagliuolo I; LaMont JT
Keio J Med; 1999 Dec; 48(4):169-74. PubMed ID: 10638139
[TBL] [Abstract][Full Text] [Related]
23. Clostridium difficile-associated disease acquired in the neurocritical care unit.
Musa SA; Robertshaw H; Thomson SJ; Cowan ML; Rahman TM
Neurocrit Care; 2010 Aug; 13(1):87-92. PubMed ID: 20443154
[TBL] [Abstract][Full Text] [Related]
24. Clinical and endoscopic features in patients with hospital-acquired diarrhea associated with Clostridium difficile infection.
Velarde Ruiz-Velasco JA; Aldana-Ledesma JM; Ibarra-Estrada MA; Aguirre Díaz SA; Fernández-Ramírez JA; Cárdenas-Lara F; Álvarez López F; Rodríguez-Noriega LE; Pérez-Gómez HR; Morfín-Otero MR
Rev Gastroenterol Mex; 2017; 82(4):301-308. PubMed ID: 28363494
[TBL] [Abstract][Full Text] [Related]
25. [Epidemiology, risk factors and prevention of Clostridium difficile nosocomial infections].
Barbut F; Petit JC
Pathol Biol (Paris); 2000 Oct; 48(8):745-55. PubMed ID: 11244603
[TBL] [Abstract][Full Text] [Related]
26. Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.
Tleyjeh IM; Bin Abdulhak AA; Riaz M; Alasmari FA; Garbati MA; AlGhamdi M; Khan AR; Al Tannir M; Erwin PJ; Ibrahim T; Allehibi A; Baddour LM; Sutton AJ
PLoS One; 2012; 7(12):e50836. PubMed ID: 23236397
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus.
Asha NJ; Tompkins D; Wilcox MH
J Clin Microbiol; 2006 Aug; 44(8):2785-91. PubMed ID: 16891493
[TBL] [Abstract][Full Text] [Related]
28. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
29. [Diarrhea associated with Clostridium difficile. One-year retrospective study at a tertiary hospital].
Barreiro PM; Pintor E; Rosario Burón M; Díaz B; Valverde J; de la Torre F
Enferm Infecc Microbiol Clin; 1998 Oct; 16(8):359-63. PubMed ID: 9835150
[TBL] [Abstract][Full Text] [Related]
30. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
López-Ureña D; Quesada-Gómez C; Montoya-Ramírez M; del Mar Gamboa-Coronado M; Somogyi T; Rodríguez C; Rodríguez-Cavallini E
Emerg Microbes Infect; 2016 May; 5(5):e42. PubMed ID: 27165560
[TBL] [Abstract][Full Text] [Related]
31. Clostridium difficile colonization in residents of long-term care facilities: prevalence and risk factors.
Walker KJ; Gilliland SS; Vance-Bryan K; Moody JA; Larsson AJ; Rotschafer JC; Guay DR
J Am Geriatr Soc; 1993 Sep; 41(9):940-6. PubMed ID: 8104968
[TBL] [Abstract][Full Text] [Related]
32. The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model.
Tomkovich S; Lesniak NA; Li Y; Bishop L; Fitzgerald MJ; Schloss PD
mSphere; 2019 Nov; 4(6):. PubMed ID: 31748246
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of Clostridium difficile-associated infections.
Barbut F; Petit JC
Clin Microbiol Infect; 2001 Aug; 7(8):405-10. PubMed ID: 11591202
[TBL] [Abstract][Full Text] [Related]
34. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
[TBL] [Abstract][Full Text] [Related]
35. Clostridium difficile infection in the intensive care unit.
Riddle DJ; Dubberke ER
Infect Dis Clin North Am; 2009 Sep; 23(3):727-43. PubMed ID: 19665092
[TBL] [Abstract][Full Text] [Related]
36. [Nosocomial epidemic outbreak of diarrhea from Clostridium difficile. Comparative study of diarrhea associated with the use of antibiotics].
Knobel H; Salvadó M; Plass E; Orfila A; Llorach I; Díez A
Med Clin (Barc); 1994 Feb; 102(5):165-8. PubMed ID: 8127164
[TBL] [Abstract][Full Text] [Related]
37. Established and potential risk factors for Clostridum difficile infection.
Vaishnavi C
Indian J Med Microbiol; 2009; 27(4):289-300. PubMed ID: 19736396
[TBL] [Abstract][Full Text] [Related]
38. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers.
Sadeghifard N; Salari MH; Ghassemi MR; Eshraghi S; Amin Harati F
Acta Med Iran; 2010; 48(5):320-5. PubMed ID: 21287466
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis.
Wilcox MH
Best Pract Res Clin Gastroenterol; 2003 Jun; 17(3):475-93. PubMed ID: 12763508
[TBL] [Abstract][Full Text] [Related]
40. Clostridium difficile colitis.
Efron PA; Mazuski JE
Surg Clin North Am; 2009 Apr; 89(2):483-500, x. PubMed ID: 19281896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
